The company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
The audit has been concluded with no major observations
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Observations are largely around improvement of procedures and practices
Biocon Biologics remains committed to global standards of quality and compliance
Subscribe To Our Newsletter & Stay Updated
